Toward a better understanding of severe asthma phenotypes in Latin America: results from the PREPARE study

References

• Global Initiative for Asthma [Internet]. Global strategy for asthma management and prevention; 2022 [cited 2022 Jun 22]. Available from: http://ginasthma.org/
   Google Scholar
• Global Asthma Network (GAN) [Internet]. The global asthma report; 2018 [cited 2022 Jun 22]. Available from: http://www.globalasthmareport.org
   Google Scholar
• Nannini LJ, Luhning S, Rojas RA, et al. Position statement: asthma in Latin America. IS short-acting beta-2 agonist helping or compromising asthma management? J Asthma. 2021;58(8):991–994.
   PubMed Web of Science ®Google Scholar
• Neffen H, Fritscher C, Schacht FC, et al. Asthma control in Latin America: the asthma insights and reality in Latin America (AIRLA) survey. Rev Panam Salud Publica. 2005;17(3):191–197.
   PubMed Web of Science ®Google Scholar
• Gold LS, Montealegre F, Allen-Ramey FC, et al. Asthma control and cost in Latin America. Value Health Reg Issues. 2014;5:25–28.
   PubMedGoogle Scholar
• Neffen H, Moraes F, Viana K, et al. Asthma severity in four countries of Latin America. BMC Pulm Med. 2019;19(1):123.
   PubMedGoogle Scholar
• Foster JM, McDonald VM, Guo M, et al. “I have lost in every facet of my life”: the hidden burden of severe asthma. Eur Respir J. 2017;50(3):1700765.
   PubMed Web of Science ®Google Scholar
• Cisternas MG, Blanc PD, Yen IH, et al. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol. 2003;111(6):1212–1218.
   PubMed Web of Science ®Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373.
   PubMed Web of Science ®Google Scholar
• Casciano J, Krishnan JA, Small MB, et al. Burden of asthma with elevated blood eosinophil levels. BMC Pulm Med. 2016;16(1):100.
   PubMedGoogle Scholar
• Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323(15):1033–1039.
   PubMed Web of Science ®Google Scholar
• Menzella F, Ruggiero P, Ghidoni G, et al. Anti-IL5 therapies for severe eosinophilic asthma: literature review and practical insights. J Asthma Allergy. 2020;13:301–313.
   PubMed Web of Science ®Google Scholar
• Pelaia C, Paoletti G, Puggioni F, et al. Interleukin-5 in the pathophysiology of severe asthma. Front Physiol. 2019;10:1514.
   PubMed Web of Science ®Google Scholar
• Castro M, Wenzel SE, Bleecker ER, et al. Benralizumab, an anti-interleukin 5 receptor alpha monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study. Lancet Respir Med. 2014;2(11):879–890.
   PubMed Web of Science ®Google Scholar
• Ying S, Meng Q, Zeibecoglou K, et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol. 1999;163(11):6321–6329. 1
   PubMed Web of Science ®Google Scholar
• Brusselle GG, Maes T, Bracke KR. Eosinophils in the spotlight: eosinophilic airway inflammation in nonallergic asthma. Nat Med. 2013;19(8):977–979.
   PubMed Web of Science ®Google Scholar
• Price DB, Rigazio A, Campbell JD, et al. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med. 2015;3(11):849–858.
   PubMed Web of Science ®Google Scholar
• Buhl R, Humbert M, Bjermer L, et al. Severe eosinophilic asthma: a roadmap to consensus. Eur Respir J. 2017;49(5):1700634.
   PubMed Web of Science ®Google Scholar
• Corren J, Weinstein S, Janka L, et al. Phase 3 study of reslizumab in patients with poorly controlled asthma: effects across a broad range of eosinophil counts. Chest. 2016;150(4):799–810.
   PubMed Web of Science ®Google Scholar
• de Groot JC, Ten Brinke A, Bel EH. Management of the patient with eosinophilic asthma: a new era begins. ERJ Open Res. 2015;1(1):00024–02015.
   PubMedGoogle Scholar
• Global Initiative for Asthma [Internet]. Global strategy for asthma management and prevention; 2018 [cited 2022 Jun 22]. Available from: http://ginasthma.org/
   Google Scholar
• Matucci A, Vultaggio A, Maggi E, et al. Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question? Respir Res. 2018;19(1):113.
   PubMedGoogle Scholar
• Katz LE, Gleich GJ, Hartley BF, et al. Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma. Ann Am Thorac Soc. 2014;11(4):531–536.
   PubMedGoogle Scholar
• Shaw DE, Sousa AR, Fowler SJ, et al. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. Eur Respir J. 2015;46(5):1308–1321.
   PubMed Web of Science ®Google Scholar
• Fuhlbrigge AL, Kitch BT, Paltiel AD, et al. FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol. 2001;107(1):61–67.
   PubMed Web of Science ®Google Scholar
• Kitch BT, Paltiel AD, Kuntz KM, et al. A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up. Chest. 2004;126(6):1875–1882.
   PubMed Web of Science ®Google Scholar
• Lloyd CM, Hessel EM. Functions of T cells in asthma: more than just Th2 cells. Nat Rev Immunol. 2010;10(12):838–848.
   PubMed Web of Science ®Google Scholar
• Eltboli O, Brightling CE. Eosinophils as diagnostic tools in chronic lung disease. Expert Rev Respir Med. 2013;7(1):33–42.
   PubMed Web of Science ®Google Scholar
• Maspero JF, Jardim JR, Aranda A, et al. Insights, attitudes, and perceptions about asthma and its treatment: findings from a multinational survey of patients from Latin America. World Allergy Organ J. 2013;6(1):19.
   PubMedGoogle Scholar
• Bedolla-Barajas M, Raúl Ortiz-Peregrina J, Daniel Hernandez-Colin D, et al. The characterization of asthma with blood eosinophilia in adults in Latin America. J Asthma. 2019;56(11):1138–1146.
   PubMed Web of Science ®Google Scholar
• Davidson AE, Klein DE, Settipane GA, et al. Access to care among children visiting the emergency room with acute exacerbations of asthma. Ann Allergy. 1994;72(5):469–473.
   PubMedGoogle Scholar
• Ferris TG, Blumenthal D, Woodruff PG, et al. Insurance and quality of care for adults with acute asthma. J Gen Intern Med. 2002;17(12):905–913.
   PubMed Web of Science ®Google Scholar
• ten Brinke A, Sterk PJ, Masclee AA, et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J. 2005;26(5):812–818.
   PubMed Web of Science ®Google Scholar
• Arabkhazaeli A, Vijverberg SJ, van Erp FC, et al. Characteristics and severity of asthma in children with and without atopic conditions: a cross-sectional study. BMC Pediatr. 2015;15:172.
   PubMed Web of Science ®Google Scholar
• Burke H, Davis J, Evans S, et al. A multidisciplinary team case management approach reduces the burden of frequent asthma admissions. ERJ Open Res. 2016;2(3):00039–2016.
   PubMedGoogle Scholar
• Patel GB, Peters AT. Comorbidities associated with severe asthma. J Precis Respir Med. 2019;2(1):5–9.
   PubMedGoogle Scholar
• Montero-Arias F, Garcia JCH, Gallego MP, et al. Over-prescription of short-acting beta(2)-agonists is associated with poor asthma outcomes: results from the Latin American cohort of the SABINA III study. J Asthma. 2022:1–14. DOI:10.1080/02770903.2022.2082305
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Schatz M, Li Q, et al. Burden of chronic oral corticosteroid use by adults with persistent asthma. J Allergy Clin Immunol Pract. 2017;5(4):1050 e9–1060 e9.
   Web of Science ®Google Scholar
• Volmer T, Effenberger T, Trautner C, et al. Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature. Eur Respir J. 2018;52(4):1800703.
   PubMed Web of Science ®Google Scholar
• Fuhlbrigge AL, Lemanske RF Jr, Rasouliyan L, et al. Practice patterns for oral corticosteroid burst therapy in the outpatient management of acute asthma exacerbations. Allergy Asthma Proc. 2012;33(1):82–89.
   PubMed Web of Science ®Google Scholar
• Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med. 2010;181(4):315–323. 15
   PubMed Web of Science ®Google Scholar
• Chan J, Hui RL, Spence MM. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids. J Manag Care Pharm. 2007;13(1):21–27.
   PubMed Web of Science ®Google Scholar
• O’Connor RD, Rosenzweig JR, Stanford RH, et al. Asthma-related exacerbations, therapy switching, and therapy discontinuation: a comparison of 3 commonly used controller regimens. Ann Allergy Asthma Immunol. 2005;95(6):535–540.
   PubMed Web of Science ®Google Scholar
• Stempel DA, Stoloff SW, Carranza Rosenzweig JR, et al. Adherence to asthma controller medication regimens. Respir Med. 2005;99(10):1263–1267.
   PubMed Web of Science ®Google Scholar
• Brüggenjürgen B, Ezzat N, Kardos P, et al. Economic evaluation of BDP/formoterol fixed vs two single inhalers in asthma treatment. Allergy. 2010;65(9):1108–1115.
   PubMed Web of Science ®Google Scholar
• Soto-Martinez M, Avila L, Soto N, et al. Trends in hospitalizations and mortality from asthma in Costa Rica over a 12- to 15-year period. J Allergy Clin Immunol Pract. 2014;2(1):85–90.
   PubMed Web of Science ®Google Scholar
• McDonald VM, Maltby S, Reddel HK, et al. Severe asthma: current management, targeted therapies and future directions-a roundtable report. Respirology. 2017;22(1):53–60.
   PubMed Web of Science ®Google Scholar
• Wang X, Cheng Z. Cross-sectional studies: strengths, weaknesses, and recommendations. Chest. 2020;158(1S):S65–S71.
   PubMed Web of Science ®Google Scholar
• Roche N, Reddel H, Martin R, et al. Quality standards for real-world research. Focus on observational database studies of comparative effectiveness. Ann Am Thorac Soc. 2014;11(Suppl 2):S99–S104.
   PubMedGoogle Scholar
• Wisniewski JA, McLaughlin AP, Stenger PJ, et al. A comparison of seasonal trends in asthma exacerbations among children from geographic regions with different climates. Allergy Asthma Proc. 2016;37(6):475–481.
   PubMed Web of Science ®Google Scholar
• Smith PC, Araya-Guerra R, Bublitz C, et al. Missing clinical information during primary care visits. JAMA. 2005;293(5):565–571.
   PubMed Web of Science ®Google Scholar
• Rodrigo GJ, Plaza V, Bellido-Casado J, et al. The study of severe asthma in Latin America and Spain (1994-2004): characteristics of patients hospitalized with acute severe asthma. J Bras Pneumol. 2009;35(7):635–644.
   PubMed Web of Science ®Google Scholar
• Casale TB, Pedersen S, Rodriguez Del Rio P, et al. The role of aeroallergen sensitization testing in asthma management. J Allergy Clin Immunol Pract. 2020;8(8):2526–2532.
   PubMed Web of Science ®Google Scholar
• Majellano EC, Clark VL, Winter NA, et al. Approaches to the assessment of severe asthma: barriers and strategies. JAA. 2019;12:235–251.
   Google Scholar
• Chung KF. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies. J Intern Med. 2016;279(2):192–204.
   PubMed Web of Science ®Google Scholar